You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists and analysts/investors.
GSK announces US regulatory submission for sirukumab in rheumatoid arthritis
GSK announces regulatory submissions for subcutaneous formulation of Benlysta® (belimumab) for patients with systemic lupus disease
It has filed regulatory submissions in the US and Europe for Benlysta® (belimumab) for approval.